Aspira Pathlab & Diagnostics Ltd share price logo

Aspira Pathlab Share Price

63.31

+0.31

(+0.49%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Aspira Pathlab Stock Performance

as on December 26, 2025 at 4:01 pm IST

  • Day's High

    ₹63.31
    ₹63.63

    0.51%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹50.49
    ₹106.78
    downward going graph

    20.25%

    Downside

    68.66%

    Upside

    downward going graph

Aspira Pathlab share price movements today

Previous Close
₹63.00
Open
₹63.63
Volume
20.00
Upper Circuit
₹69.30
Lower Circuit
₹56.70
Day's Low - High
₹63.31 - ₹63.63
52 Week Low - High
₹50.49 - ₹106.78

Aspira Pathlab Historical Returns

1 Month Return
-2.79 %
3 Month Return
+ 2.41 %
1 Year Return
+ 7.31 %
3 Year Return
+ 57.96 %
5 Year Return
+ 137.08 %

Aspira Pathlab Fundamentals

as on December 26, 2025 at 4:01 pm IST

Market Cap

₹65.28 Cr

Return on Equity (ROE)

16.88

PE Ratio (TTM)

27.22

Return on capital employed (ROCE)

11.71

Industry PE ratio

49.42

Beta (LTM)

0.37

P/B Ratio

12.04

Dividend Yield

0

PEG Ratio

7.84

Quarterly Earnings Growth YOY

740

EPS (TTM)

1.97

Sector

Healthcare

Book Value

7.03

Technical Analysis

Aspira Pathlab Stock Valuation

as on December 26, 2025 at 4:01 pm IST

Aspira Pathlab in the last 5 years

  • Overview

  • Trends

Lowest (-433.33x)

November 29, 2024

Today (27.22x)

December 26, 2025

Industry (49.42x)

December 26, 2025

Highest (124.02x)

March 24, 2025

LowHigh

Today’s Price to Earnings Ratio: 27.22x

Aspira Pathlab & Diagnostics Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aspira Pathlab with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA65.2827.42%0.58222
BUY4,180.75136.05%0.001601,356
NA112.193.07%0.504559
BUY2,372.08-5.18%0.6077723
NA37.74-11.02%0.51175

Aspira Pathlab Share Price Target

Get share price movements and forecasts by analysts on Aspira Pathlab.

Source: S&P Global Market Intelligence

Aspira Pathlab Stock’s Investor Sentiment and Interest

Search interest for Aspira Pathlab & Diagnostics Ltd Stock has increased by 31% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:31% versus previous 30 day period

Aspira Pathlab & Diagnostics Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
2.6
3.82
4.64
6.18
5.41
5.78
5.25
Other Income
0.1
0.08
0.16
0.08
0.09
0.13
0.11
Total Income
2.7
3.89
4.79
6.25
5.5
5.91
5.36
Expenses
3.03
4.02
4.37
4.9
4.8
4.86
4.57
Operating Profit
-0.43
-0.2
0.27
1.28
0.61
0.92
0.68
Operating Profit Margin %
-16.54%
-5.24%
5.82%
20.71%
11.28%
15.92%
12.95%
Profit Before Interest, Tax and Depreciation
-0.32
-0.13
0.42
1.35
0.69
1.05
0.79
Depreciation
0.39
0.38
0.38
0.36
0.39
0.37
0.37
Profit Before Tax
-0.71
-0.51
0.04
0.99
0.3
0.68
0.42
Profit After Tax
-0.72
-0.5
0.05
0.99
0.31
0.68
0.42
Total Net profit including share of profit / Loss from associate company
-0.72
-0.5
0.05
0.99
0.31
0.68
0.42
EPS
-0.7
-0.49
0.05
0.96
0.3
0.66
0.41
Actual EPS
-0.7
-0.49
0.05
0.96
0.3
0.66
0.41
Adjusted EPS
-0.7
-0.49
0.05
0.96
0.3
0.66
0.41
Diluted EPS
-0.7
-0.49
0.05
0.96
0.3
0.66
0.41

Aspira Pathlab & Diagnostics Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2024
Mar 2025
Sales
13.2
22
Other Income
0.42
0.39
Total Income
13.63
22.39
Expenses
14.76
18.87
Operating Profit
-1.56
3.13
Operating Profit Margin %
-11.82%
14.23%
Profit Before Interest, Tax and Depreciation
-1.13
3.52
Depreciation
1.54
1.49
Profit Before Tax
-2.67
2.03
Profit After Tax
-2.67
2.02
Total Net profit including share of profit / Loss from associate company
-2.67
2.02
EPS
-2.6
1.97
Actual EPS
-2.6
1.97
Adjusted EPS
-2.6
1.97
Diluted EPS
-2.6
1.97

Aspira Pathlab & Diagnostics Ltd Cash Flow

Figures in Rupees Crores

Mar 2024
Mar 2025
Net Cash from Operating Activities
1.05
1.83
Cash Flow from Investing Activities
0.14
0.12
Cash Flow from Financing Activities
-0.95
-1
Net Cash Flow
0.24
0.95

Aspira Pathlab Corporate Actions

View detailed summary of the earnings and dividend history of Aspira Pathlab.

  • Aspira Pathlab & Diagnostics Ltd Earnings Results

    Aspira Pathlab & Diagnostics Ltd’s net profit jumped 740% since last year same period to ₹0.42Cr in the Q1 2025-2026. On a quarterly growth basis, Aspira Pathlab & Diagnostics Ltd has generated -38.24% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Aspira Pathlab & Diagnostics Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, Aspira Pathlab stock has moved up by 2.1%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 81.61% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Fortis Healthcare Ltd has given 220.7% return, outperforming this stock by 162.8%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 18.39% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Narayana Hrudayalaya Ltd has given 43.3% return, outperforming this stock by 36.0%

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab Diagnostics Limited is a public limited company established in July 03rd 1973, specializing in pathology investigation services, radiology investigation services and other related healthcare services at their Diagnostic Centres in Mumbai. The Company increased its paid-up capital from 5193000 equity shares of Rs. 10/ each to 136930000 divided into 8193000 equity shares and 5500000 Non-Cumulative Non-convertible Non-Participating Redeemable Preference Shares of Rs. 10/ each during 2018-19 and got its delisting approval from Metropolitan Stock Exchange of India Limited and Calcutta Stock Exchange Limited on 12th April 2018 and 15th October 2018 respectively. During the year 2016, they acquired the running business of Ankur Pathology Laboratory and issued 2943000 equity shares of Rs. 10/ each for Rs. 17/ per share, including a share premium of Rs. 7/ per share on a preferential basis to promoters. In order to widen their reach, they applied to the BSE Limited in 2017 for its listing and trading. Their registered office was shifted from West Bengal to Maharashtra and then - from within Mumbai city limits in 2017.

Revenue: ₹5.25Cr as on June 2025 (Q1 FY26)
Net Profit: ₹0.42Cr as on June 2025 (Q1 FY26)
Chairperson Name: Haseeb Drabu
OrganisationAspira Pathlab & Diagnostics Ltd
HeadquartersMumbai
IndustryHealthcare
CEOHaseeb Drabu
E-voting on sharesClick here to vote

FAQs

What is Aspira Pathlab share price today?

Aspira Pathlab share price today stands at ₹63.31 as on at the close of the market. Aspira Pathlab share today touched a day high of ₹63.63 and a low of ₹63.31.

What is the 52 week high and 52 week low range for Aspira Pathlab share?

Aspira Pathlab touched a 52 week high of ₹106.78 and a 52 week low of ₹50.49. Aspira Pathlab share price today i.e. is closed at ₹63.31, which is -40.71% down from its 52 week high and 25.39% up from its 52 week low.

What is Aspira Pathlab's market capitalisation today?

Aspira Pathlab market capitalisation is ₹65.28 Cr as on .

How to buy Aspira Pathlab shares?

To buy Aspira Pathlab shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 540788 or Aspira Pathlab & Diagnostics Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Aspira Pathlab shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Aspira Pathlab trading volume today?

Aspira Pathlab trading volume is 20.00 as on . This means that 20.00 shares of Aspira Pathlab were bought and sold on the stock market during today's trading session.